IPR in Successful University - Industry Collaborations

Company Logo

Cengiz A TarhanManaging DirectorUCL Business PLC

UCL

Enterprise at UCL – role of UCLB

Why we collaborate

Recent examples

Summary

Over view

Established over 180 years ago

First university in England to admit students of any race, class or religion, welcome women on equal terms teach experimental science, modern European languages, Laws…

Today – over 4000 researchers and

Ranked 5th in the QS World University rankings for 2014 and 20th in the Academic Ranking of World Universities - 2014 (3rd in Europe)

Exceptional strength in BioMedicine

UCL – London’s Global Univers i tyUCL – London’s Global Univers i ty

“UCL ranked the leading institution in the UK as a partner for

industry in the biotechnology and pharmaceutical sectors”

May 2013

Over view

Enterpr ise at UCL i s evolv ing

Why we col laborate with Industry

It makes sense Best universities and best companies do Symbiotic relationship – should be two way Helps achieve our mission to make IMPACT But;

Pick your partners well Protect your reputation Remain flexible on terms Document the arrangement Manage the relationship

Direct Studentships – beware of IP leakage Consultancy – IP rights defined within agreement Contract research – usually IP vested in company Collaborative research – complex IP negotiation Strategic partnerships – multiple programs

Indirect Through UCL’s spin out companies Through our partner hospitals

E xa m p l e s o f c o l l a b o ra ti o n w i t h I n d u s t r y a t U C L

Overvaluing IP Undervaluing IP Warranties and indemnities Access to Background IP Licensing versus assigning Ownership of Arising/Foreground IP Money – costs/upfront/milestones/royalties Termination – what happens to IP And more!

When IP i s Involved

Eisai – drug discovery alliance Pfizer – collaboration on stem cell- based technology Novozymes BioPharma – combining technology platforms Cell Therapy Catapult – treatment for leukaemia Novo Nordisk – mapping diabetes Takeda – tackling muscle disorders and muscular dystrophy

Recent examples of collaborative research at UCL

Most high tech displays and touchscreens are made of transparent conductive film which requires Indium Tin Oxide (ITO)

Costs of processing ITO are high and screens tend to be brittle – not suitable for flexible displays.

Collaboration with Linde is based on developing a solution to use Single walled carbon nanotubes (SWCN) as an alternative.

Unlock ing the potential of Carbon Nanotubes

Researchers at UCL identified a way of purifying the SWCN’s to make them useful for new generation flexible screens.

Unlock ing the potential of Carbon Nanotubes

Patent protection secured Licence to Linde Group in 2011 Linde Nanomaterials formed in 2012 with manufacturing

facility in San Marcos, California SEERe- Ink launched in 2013 Potential highlighted in Touch Display Research Inc., ITO-

replacement report, May 2014) estimating non ITO-transparent conducting films market is likely to be worth $8.1billion by 2021

Unlock ing the potential of Carbon Nanotubes

UCL is committed to Enterprise to deliver IMPACT

Engagement with Industry is crucial

IPR plays an important role

It’s a relationship with ‘ups and downs’

Successful relationship needs to be ‘managed’

Summary